Insider Transactions in Q4 2023 at Mirati Therapeutics, Inc. (MRTX)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 29
2023
|
Aaron I. Davis |
BUY
Grant, award, or other acquisition
|
Direct |
6,808
+11.14%
|
$394,864
$58.75 P/Share
|
Dec 29
2023
|
Craig A Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
6,808
+28.27%
|
$394,864
$58.75 P/Share
|
Dec 29
2023
|
Maria E Martinez |
BUY
Grant, award, or other acquisition
|
Direct |
6,808
+28.27%
|
$394,864
$58.75 P/Share
|
Dec 29
2023
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
6,808
+32.16%
|
$394,864
$58.75 P/Share
|
Dec 29
2023
|
Julie M Cherrington |
BUY
Grant, award, or other acquisition
|
Direct |
6,808
+37.7%
|
$394,864
$58.75 P/Share
|
Dec 29
2023
|
Shalini Sharp |
BUY
Grant, award, or other acquisition
|
Direct |
6,808
+29.56%
|
$394,864
$58.75 P/Share
|
Dec 29
2023
|
Bruce L A Carter |
BUY
Grant, award, or other acquisition
|
Direct |
6,808
+28.27%
|
$394,864
$58.75 P/Share
|
Dec 29
2023
|
Faheem Hasnain |
BUY
Grant, award, or other acquisition
|
Direct |
9,702
+28.16%
|
$562,716
$58.75 P/Share
|
Dec 29
2023
|
Benjamin Hickey EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,021
+12.36%
|
$987,218
$58.75 P/Share
|
Dec 29
2023
|
Jamie Christensen EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,021
+9.69%
|
$987,218
$58.75 P/Share
|
Dec 29
2023
|
Alan B. Sandler Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,021
+17.67%
|
$987,218
$58.75 P/Share
|
Dec 29
2023
|
Aaron Ondrey Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,021
+30.14%
|
$987,218
$58.75 P/Share
|
Dec 29
2023
|
Charles M Baum Founder, President, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,425
+7.62%
|
$1,184,650
$58.75 P/Share
|
Dec 18
2023
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,387
-1.66%
|
$136,059
$57.5 P/Share
|
Dec 13
2023
|
Benjamin Hickey EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,220
-2.1%
|
$124,320
$56.67 P/Share
|